Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2008 Mar 5;28(10):2313-9.
doi: 10.1523/JNEUROSCI.5603-07.2008.

Cannabinoid modulation of amygdala reactivity to social signals of threat in humans

Affiliations
Randomized Controlled Trial

Cannabinoid modulation of amygdala reactivity to social signals of threat in humans

K Luan Phan et al. J Neurosci. .

Abstract

The cannabinoid (CB) system is a key neurochemical mediator of anxiety and fear learning in both animals and humans. The anxiolytic effects of delta(9)-tetrahydrocannabinol (THC), the primary psychoactive ingredient in cannabis, are believed to be mediated through direct and selective agonism of CB(1) receptors localized within the basolateral amygdala, a critical brain region for threat perception. However, little is known about the effects of THC on amygdala reactivity in humans. We used functional magnetic resonance imaging and a well validated task to probe amygdala responses to threat signals in 16 healthy, recreational cannabis users after a double-blind crossover administration of THC or placebo. We found that THC significantly reduced amygdala reactivity to social signals of threat but did not affect activity in primary visual and motor cortex. The current findings fit well with the notion that THC and other cannabinoids may have an anxiolytic role in central mechanisms of fear behaviors and provide a rationale for exploring novel therapeutic strategies that target the cannabinoid system for disorders of anxiety and social fear.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
THC effects on self-report measures. Mean “feel drug” (DEQ) (A), “drug high” (DEQ) (B), and “high” (VAS) (C) scores over time after oral administration of THC (solid line; open circles) or PBO (dashed line; closed circles). Means are based on DEQ data from 14 subjects and VAS data from 15 subjects. Error bars represent SEM. *p < 0.05, two-tailed.
Figure 2.
Figure 2.
THC effects on amygdala activation. A, B, Statistical t maps overlaid on a canonical brain rendering (MNI coronal y-plane = 0) showing right lateral amygdala activation to threat (>nonthreat) faces is present during the PBO session but absent during the THC session. C, Statistical t map overlaid on a canonical brain rendering (MNI coronal y-plane = 0) showing greater threat-related amygdala reactivity in the PBO relative to the THC session (PBO > THC). For additional information, see Results. Statistical t score scale is shown at the bottom of the brain rendering. R, Right.

Similar articles

Cited by

References

    1. Abood ME, Martin BR. Neurobiology of marijuana abuse. Trends Pharmacol Sci. 1992;13:201–206. - PubMed
    1. Adolphs R. Neural systems for recognizing emotion. Curr Opin Neurobiol. 2002;12:169–177. - PubMed
    1. Adolphs R, Gosselin F, Buchanan TW, Tranel D, Schyns P, Damasio AR. A mechanism for impaired fear recognition after amygdala damage. Nature. 2005;433:68–72. - PubMed
    1. Berrendero F, Maldonado R. Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol. Psychopharmacology (Berl) 2002;163:111–117. - PubMed
    1. Chait LD, Zacny JP. Reinforcing and subjective effects of oral delta 9-THC and smoked marijuana in humans. Psychopharmacology (Berl) 1992;107:255–262. - PubMed

Publication types